Current Drug Targets


Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556


Become EABM
Become Reviewer

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

Volume:20   Issue: 9
Pp: 891-902
Yucui Zhao and Siyu Chen*
DOI: 10.2174/1389450120666190222181857

Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement

Volume:20   Issue: 9
Pp: 903-918
Francesca Liva, Doretta Cuffaro, Elisa Nuti, Susanna Nencetti, Elisabetta Orlandini, Giovanni Vozzi and Armando Rossello*
DOI: 10.2174/1389450120666190122114857

Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials

Volume:20   Issue: 9
Pp: 919-937
Natiele C. da Silva Ferreira, Luiz A. Alves and Rômulo J. Soares-Bezerra*
DOI: 10.2174/1389450120666190213095923

Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology

Volume:20   Issue: 9
Pp: 938-941
Victor Y. Glanz, Veronika A. Myasoedova, Andrey V. Grechko and Alexander N. Orekhov*
DOI: 10.2174/1389450120666190308111619

Current Understanding of Group A Streptococcal Biofilms open access plus

Volume:20   Issue: 9
Pp: 982-993
Heema K.N. Vyas, Emma-Jayne Proctor, Jason McArthur, Jody Gorman and Martina Sanderson-Smith*
DOI: 10.2174/1389450120666190405095712